Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cancer Research|September 14, 2013
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancerSusana Garcia-Recio, Gemma Fuster, Patricia Fernandez-Nogueira, et al.Breast Cancer Research : BCR|July 6, 2018
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosisArantzazu Zubeldia-Plazaola, Leire Recalde-Percaz, Núria Moragas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2019
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 ActivationPatricia Fernández-Nogueira, Mario Mancino, Gemma Fuster, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2015
The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 PseudokinaseTatiana Erazo, Mar Lorente, Anna López-Plana, et al.Cancer Research|November 8, 2019
Epigenetic SMAD3 Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell CarcinomaRafael Ikemori, Marta Gabasa, Paula Duch, et al.International Journal of Cancer|January 17, 2020
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancerAnna López-Plana, Patricia Fernández-Nogueira, Pau Muñoz-Guardiola, et al.Pageof 4